仕様
| 項目 | 製品情報 |
|---|---|
| 認証 | CE認証 |
| HA濃度 | 20 mg/mL |
| 顔用シリーズ | 1 mL × シリンジ1本 |
| ボディ用シリーズ | 10 mL × シリンジ1本 |
顔用モデル
| モデル | 粒子径 | 針 | 包装形態 |
|---|---|---|---|
| Soft | 200 µm | 30G / 13 mm | 1 mL × シリンジ1本 |
| Mid | 350 µm | 27G / 13 mm | 1 mL × シリンジ1本 |
| Ultra | 450 µm | 25G / 13 mm | 1 mL × シリンジ1本 |
ボディ用モデル
| モデル | 粒子径 | 針 | 包装形態 |
|---|---|---|---|
| Classic-H | 400 µm | 20–21G / 50 mm | 10 mL × シリンジ1本 |
| Classic-S | 250 µm | 21–23G / 50 mm | 10 mL × シリンジ1本 |
技術・素材
カタログではMCL（Multi Staged Crosslinking）による架橋HAマイクロビーズ構造と、顔用シリーズの超薄壁針が説明されています。原料供給元としてShiseido Co., Ltd.を挙げ、DVS・MDAWO洗浄技術と97%以上という純度を記載しています。
英語原文の詳細情報
以下に製品ガイドの英語原文を保持しています。上記の翻訳概要・仕様表は資料を構造的に整理したもので、PDFはメーカーまたは提供元の原本です。
A CE-certified hyaluronic acid dermal-filler collection with three face variants — Soft, Mid and Ultra — and two body variants — Classic-H and Classic-S. All five variants contain HA 20 mg/mL, with different particle sizes and delivery specifications.
Face collection: Soft, Mid and Ultra
Three face variants provide different particle sizes and needle gauges. Each contains HA 20 mg/mL in a 1 mL syringe. The catalogue specifies ultra-thin-wall needles for all three variants.
| Specification | Soft | Mid | Ultra |
|---|---|---|---|
| HA concentration | 20 mg/mL | 20 mg/mL | 20 mg/mL |
| Particle size | 200 µm | 350 µm | 450 µm |
| Needle gauge | 30G | 27G | 25G |
| Needle length | 13 mm | 13 mm | 13 mm |
| Pack | 1 mL × 1 syringe | 1 mL × 1 syringe | 1 mL × 1 syringe |
Applicable facial areas
The catalogue maps each variant to the following facial areas.
| Area | Catalogue variant |
|---|---|
| Fine wrinkles | Soft |
| Lips | Soft / Mid |
| Deep wrinkles | Mid |
| Forehead | Mid |
| Cheekbone | Ultra / Mid |
| Nose | Ultra |
| Nasolabial area | Ultra |
| Short chin | Ultra |
Body collection: Classic-H and Classic-S
The body collection contains HA 20 mg/mL and is supplied as 10 mL × 1 syringe. Classic-H and Classic-S differ in particle size and cannula specifications.
| Specification | Classic-H | Classic-S |
|---|---|---|
| HA concentration | 20 mg/mL | 20 mg/mL |
| Particle size | 400 µm | 250 µm |
| Cannula gauge | 20–21G | 21–23G |
| Cannula length | 50 mm | 50 mm |
| Pack | 10 mL × 1 syringe | 10 mL × 1 syringe |
MCL microbead architecture
MCL is described as Multi Staged Crosslinking. The catalogue presents a crosslinked HA microbead structure: ultrafine beads formed from HA molecules are united into new beads, followed by further bead assembly.
The material photograph presents K’belle Ultra in a semi-solid gel state.
- Crosslinked HA microbeads.
- Multi-stage bead architecture.
- Semi-solid gel presentation.
Raw material and manufacturing information
The catalogue names Shiseido Co., Ltd. as the raw-material source and references the European Pharmacopoeia. It describes DVS and MDAWO washing technology, with a stated purity of 97% or more.
Particle-size comparison
| Specification | Product “P” | K’belle |
|---|---|---|
| Particle size | 1,000 µm | 450 µm |
| HA concentration | 20 mg/mL | 20 mg/mL |
Material characterisation
The brochure reproduces a spectral comparison of HA raw material and finished product.
The hydrophilicity / centrifuge test uses a 1 cc sample in 500 cc water at 3,000 rpm for 30 minutes. The reported remaining amounts are shown below.
The brochure identifies these as bench observations, not clinical safety or efficacy findings, and specifies that they are not a claim of injected volume gain.
| Sample | Reported remaining amount |
|---|---|
| A | 4 cc |
| B | 4 cc |
| C | 4.5 cc |
| K’belle | 15.5 cc |
業務に関するお問い合わせ
会社名、仕向国、希望モデル、数量をご記入ください。メールアプリが開きます。お問い合わせが自動送信・保存されることはありません。
alexmoon@ictmedicalco.com ↗